Cover picture
Authors' picture

Michel Janicot, PhD


Dr. Michel Janicot holds a Ph.D. degree in Biochemistry (Molecular and Cellular Biology) from the University of Paris VII (France) after which he was Postdoctoral Fellow at The Johns Hopkins University (Baltimore, MD. USA). Dr. Janicot has over 25 years hands-on experience in preclinical and early clinical pharmaceutical drug development in increasing leadership roles at Rhone-Poulenc Rorer (Sanofi) and subsequently at Janssen (Johnson & Johnson).

Since 2012, Dr. Janicot is the founder and Managing Director of JMi ONConsulting, a firm specialized in providing consulting services and guidances for R&D programs in the field of Oncology, Inflammation, Immunology, Fibrosis and Ophthalmology. Under this business umbrella, Dr. Janicot is part-time management team member (acting CSO/CDO) in various companies. He is also co-founder and Board member of aPODD, a non-profit foundation focusing on Pediatric Oncology Drug Development.